Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.0900
- TODAY'S CHANGE (%)0.1200 (0.4290%)
- Bid / Lots28.0000/ 20
- Ask / Lots29.0000/ 1
- Open / Previous Close28.5000 / 27.9700
- Day Range
- 52 Week Range
- Volume2,879,936
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 50345 | 28.27 |
| 09:34 ET | 6139 | 28.35 |
| 09:36 ET | 3838 | 28.355 |
| 09:38 ET | 7113 | 28.38 |
| 09:39 ET | 3601 | 28.39 |
| 09:41 ET | 8231 | 28.31 |
| 09:43 ET | 4569 | 28.27 |
| 09:45 ET | 6484 | 28.27 |
| 09:48 ET | 5290 | 28.3 |
| 09:50 ET | 4428 | 28.32 |
| 09:52 ET | 231875 | 28.43 |
| 09:54 ET | 7784 | 28.5492 |
| 09:56 ET | 6200 | 28.52 |
| 09:57 ET | 6550 | 28.44 |
| 09:59 ET | 6021 | 28.47 |
| 10:01 ET | 4318 | 28.45 |
| 10:03 ET | 3030 | 28.47 |
| 10:06 ET | 7450 | 28.485 |
| 10:08 ET | 4507 | 28.515 |
| 10:10 ET | 6451 | 28.47 |
| 10:12 ET | 9932 | 28.43 |
| 10:14 ET | 6664 | 28.35 |
| 10:15 ET | 3969 | 28.35 |
| 10:17 ET | 11506 | 28.3939 |
| 10:19 ET | 15829 | 28.37 |
| 10:21 ET | 10472 | 28.28 |
| 10:24 ET | 3158 | 28.26 |
| 10:26 ET | 4273 | 28.27 |
| 10:28 ET | 5261 | 28.305 |
| 10:30 ET | 13708 | 28.235 |
| 10:32 ET | 6106 | 28.22 |
| 10:33 ET | 3950 | 28.25 |
| 10:35 ET | 3193 | 28.245 |
| 10:37 ET | 6046 | 28.195 |
| 10:39 ET | 10366 | 28.225 |
| 10:42 ET | 5355 | 28.245 |
| 10:44 ET | 5737 | 28.265 |
| 10:46 ET | 3670 | 28.29 |
| 10:48 ET | 3937 | 28.34 |
| 10:50 ET | 4253 | 28.36 |
| 10:51 ET | 4085 | 28.37 |
| 10:53 ET | 6684 | 28.35 |
| 10:55 ET | 32186 | 28.4 |
| 10:57 ET | 19270 | 28.41 |
| 11:00 ET | 28049 | 28.355 |
| 11:02 ET | 2360 | 28.305 |
| 11:04 ET | 6526 | 28.31 |
| 11:06 ET | 3831 | 28.28 |
| 11:08 ET | 3210 | 28.265 |
| 11:09 ET | 1898 | 28.265 |
| 11:11 ET | 3797 | 28.29 |
| 11:13 ET | 5689 | 28.24 |
| 11:15 ET | 6371 | 28.28 |
| 11:18 ET | 2300 | 28.285 |
| 11:20 ET | 2404 | 28.32 |
| 11:22 ET | 1202 | 28.315 |
| 11:24 ET | 5223 | 28.295 |
| 11:26 ET | 3952 | 28.325 |
| 11:27 ET | 1800 | 28.33 |
| 11:29 ET | 2933 | 28.34 |
| 11:31 ET | 500 | 28.3384 |
| 11:33 ET | 4989 | 28.3668 |
| 11:36 ET | 8447 | 28.375 |
| 11:38 ET | 1375 | 28.385 |
| 11:40 ET | 4447 | 28.39 |
| 11:42 ET | 1600 | 28.385 |
| 11:44 ET | 5595 | 28.38 |
| 11:45 ET | 10164 | 28.375 |
| 11:47 ET | 1367 | 28.405 |
| 11:49 ET | 9640 | 28.41 |
| 11:51 ET | 2992 | 28.38 |
| 11:54 ET | 7221 | 28.385 |
| 11:56 ET | 3500 | 28.42 |
| 11:58 ET | 1716 | 28.425 |
| 12:00 ET | 6160 | 28.415 |
| 12:02 ET | 9096 | 28.36 |
| 12:03 ET | 1675 | 28.34 |
| 12:05 ET | 7121 | 28.29 |
| 12:07 ET | 10381 | 28.305 |
| 12:09 ET | 7900 | 28.34 |
| 12:12 ET | 2266 | 28.34 |
| 12:14 ET | 3783 | 28.37 |
| 12:16 ET | 7837 | 28.365 |
| 12:18 ET | 582 | 28.365 |
| 12:20 ET | 6156 | 28.355 |
| 12:21 ET | 1855 | 28.35 |
| 12:23 ET | 4741 | 28.3327 |
| 12:25 ET | 4181 | 28.335 |
| 12:27 ET | 4877 | 28.33 |
| 12:30 ET | 3757 | 28.31 |
| 12:32 ET | 6651 | 28.31 |
| 12:34 ET | 1749 | 28.305 |
| 12:36 ET | 4224 | 28.31 |
| 12:38 ET | 7067 | 28.29 |
| 12:39 ET | 2500 | 28.265 |
| 12:41 ET | 3254 | 28.28 |
| 12:43 ET | 1565 | 28.305 |
| 12:45 ET | 3737 | 28.295 |
| 12:48 ET | 1208 | 28.3 |
| 12:50 ET | 4300 | 28.335 |
| 12:52 ET | 3373 | 28.34 |
| 12:54 ET | 846 | 28.34 |
| 12:56 ET | 4851 | 28.365 |
| 12:57 ET | 4837 | 28.345 |
| 12:59 ET | 3704 | 28.325 |
| 01:01 ET | 1898 | 28.335 |
| 01:03 ET | 9671 | 28.335 |
| 01:06 ET | 1500 | 28.355 |
| 01:08 ET | 4780 | 28.315 |
| 01:10 ET | 909 | 28.315 |
| 01:12 ET | 2920 | 28.315 |
| 01:14 ET | 5769 | 28.315 |
| 01:15 ET | 1537 | 28.305 |
| 01:17 ET | 13832 | 28.255 |
| 01:19 ET | 1000 | 28.265 |
| 01:21 ET | 3820 | 28.255 |
| 01:24 ET | 8319 | 28.29 |
| 01:26 ET | 2431 | 28.265 |
| 01:28 ET | 1056 | 28.2701 |
| 01:30 ET | 2637 | 28.275 |
| 01:32 ET | 700 | 28.275 |
| 01:33 ET | 1555 | 28.2877 |
| 01:35 ET | 1496 | 28.29 |
| 01:37 ET | 9686 | 28.28 |
| 01:39 ET | 800 | 28.28 |
| 01:42 ET | 975 | 28.285 |
| 01:44 ET | 400 | 28.285 |
| 01:46 ET | 8188 | 28.295 |
| 01:48 ET | 10365 | 28.31 |
| 01:50 ET | 200 | 28.315 |
| 01:51 ET | 16223 | 28.335 |
| 01:53 ET | 595 | 28.3309 |
| 01:55 ET | 4606 | 28.345 |
| 01:57 ET | 12065 | 28.4 |
| 02:00 ET | 54912 | 28.395 |
| 02:02 ET | 7336 | 28.405 |
| 02:04 ET | 14027 | 28.405 |
| 02:06 ET | 51322 | 28.31 |
| 02:08 ET | 4488 | 28.36 |
| 02:09 ET | 3093 | 28.355 |
| 02:11 ET | 3495 | 28.315 |
| 02:13 ET | 2271 | 28.28 |
| 02:15 ET | 3333 | 28.305 |
| 02:18 ET | 9136 | 28.27 |
| 02:20 ET | 5149 | 28.26 |
| 02:22 ET | 1303 | 28.245 |
| 02:24 ET | 3369 | 28.225 |
| 02:26 ET | 4655 | 28.245 |
| 02:27 ET | 6998 | 28.205 |
| 02:29 ET | 4313 | 28.2 |
| 02:31 ET | 3800 | 28.195 |
| 02:33 ET | 4286 | 28.1911 |
| 02:36 ET | 3797 | 28.2 |
| 02:38 ET | 1300 | 28.195 |
| 02:40 ET | 2542 | 28.195 |
| 02:42 ET | 7344 | 28.195 |
| 02:44 ET | 3221 | 28.21 |
| 02:45 ET | 900 | 28.21 |
| 02:47 ET | 11461 | 28.215 |
| 02:49 ET | 6399 | 28.22 |
| 02:51 ET | 5068 | 28.255 |
| 02:54 ET | 12149 | 28.295 |
| 02:56 ET | 4360 | 28.26 |
| 02:58 ET | 1300 | 28.27 |
| 03:00 ET | 13341 | 28.255 |
| 03:02 ET | 6900 | 28.235 |
| 03:03 ET | 4256 | 28.205 |
| 03:05 ET | 3450 | 28.205 |
| 03:07 ET | 2076 | 28.19 |
| 03:09 ET | 3410 | 28.2 |
| 03:12 ET | 934 | 28.195 |
| 03:14 ET | 5159 | 28.185 |
| 03:16 ET | 5045 | 28.195 |
| 03:18 ET | 2505 | 28.185 |
| 03:20 ET | 3899 | 28.195 |
| 03:21 ET | 10005 | 28.165 |
| 03:23 ET | 12938 | 28.13 |
| 03:25 ET | 7939 | 28.14 |
| 03:27 ET | 3866 | 28.155 |
| 03:30 ET | 13149 | 28.149 |
| 03:32 ET | 7303 | 28.17 |
| 03:34 ET | 4564 | 28.1506 |
| 03:36 ET | 5788 | 28.155 |
| 03:38 ET | 3928 | 28.145 |
| 03:39 ET | 8908 | 28.11 |
| 03:41 ET | 23801 | 28.115 |
| 03:43 ET | 13207 | 28.12 |
| 03:45 ET | 22058 | 28.135 |
| 03:48 ET | 13774 | 28.09 |
| 03:50 ET | 10961 | 28.07 |
| 03:52 ET | 53820 | 28.055 |
| 03:54 ET | 48442 | 28.075 |
| 03:56 ET | 92496 | 28.1 |
| 03:57 ET | 85306 | 28.105 |
| 03:59 ET | 472024 | 28.09 |
May 9, 2024
Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow Jones*DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
7:00AM ET on Thursday May 09, 2024 by Dow JonesRoyalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow JonesPress Release: Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
6:45AM ET on Thursday May 09, 2024 by Dow Jones
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.8B | 15.8x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.8x | --- |
Catalent Inc | 10.1B | -8.6x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.6x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.5B | -42.9x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.99% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.8x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
